Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia. | BMC Med Genomics | 2023 | 37596597 | PubTator, text mining | PubMed |
| m6A methylation: a potential key player in understanding and treating COVID-2019 infection. | Cell Death Discov | 2023 | 37596265 | PubTator, text mining | PubMed |
| A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC. | World J Surg Oncol | 2023 | 37592311 | PubTator, text mining | PubMed |
| A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression. | Elife | 2023 | 37589705 | PubTator, text mining | PubMed |
| Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells. | Open Med (Wars) | 2023 | 37588656 | PubTator, text mining | PubMed |
| ALKBH5 inhibitors as a potential treatment strategy in heart failure-inferences from gene expression profiling. | Front Cardiovasc Med | 2023 | 37583580 | PubTator, text mining | PubMed |
| m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. | Mol Cancer | 2023 | 37582735 | PubTator, text mining | PubMed |
| Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. | Cell Biosci | 2023 | 37580808 | PubTator, text mining | PubMed |
| Functional Roles of lncRNAs in Recurrent Pregnancy Loss: A Review Study. | Int J Fertil Steril | 2023 | 37577902 | PubTator, text mining | PubMed |
| Environmental Determinants of Ferroptosis in Cancer. | Cancers (Basel) | 2023 | 37568677 | PubTator, text mining | PubMed |
| Co-effects of m6A and chromatin accessibility dynamics in the regulation of cardiomyocyte differentiation. | Epigenetics Chromatin | 2023 | 37568210 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma. | BMC Genom Data | 2023 | 37568073 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression. | Cell Commun Signal | 2023 | 37563688 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications. | Heliyon | 2023 | 37560684 | PubTator, text mining | PubMed |
| Development and verification of a deep learning-based m6A modification model for clinical prognosis prediction of renal cell carcinoma. | J Cancer Res Clin Oncol | 2023 | 37558767 | PubTator, text mining | PubMed |
| PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6. | Cell Death Dis | 2023 | 37558663 | PubTator, text mining | PubMed |
| Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder. | iScience | 2023 | 37554463 | PubTator, text mining | PubMed |
| Role of TNF-α-induced m6A RNA methylation in diseases: a comprehensive review. | Front Cell Dev Biol | 2023 | 37554306 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| The crucial roles of m6A RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies. | Genes Dis | 2023 | 37554186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=48